Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database.

被引：0
|
作者：
Ricciuti, Biagio [1 ]
Wang, Chenguang [2 ]
Rizvi, Hira [3 ]
Egger, Jacklynn [1 ]
LeNoue-Newton, Michele [4 ]
Holt, Marilyn [4 ]
Aggarwal, Shivani
Tu, Huakang [5 ]
Hsu, Hil [5 ]
Wang, Xuena [5 ]
Ngarmchamnanrith, Gataree [5 ]
Chia, Victoria [5 ]
Lee, Jocelyn [6 ]
Scharpf, Robert [2 ]
Anagnostou, Valsamo [2 ]
Lovly, Christine [4 ]
Riely, Greg [3 ]
Awad, Mark [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Amer Assoc Canc Res, Philadelphia, PA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
102
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adagrasib (MRTX849) in patients with advanced/metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC): Preliminary analysis of mutation allele frequency
    Janne, P. A.
    Spira, A.
    Riely, G. J.
    Gadgeel, S.
    Heist, R.
    Ou, S-H. I.
    Johnson, M. L.
    Sabari, J.
    Velastegui, K.
    Christensen, J. G.
    Yang, W.
    Anderes, K.
    Chao, R.
    Paweletz, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S41 - S42
  • [32] Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): An AACR Project GENIE analysis.
    Rahman, Protiva
    LeNoue-Newton, Michele
    Chaugai, Sandip
    Holt, Marilyn
    Jain, Neha M.
    Maxwell, Christina
    Micheel, Christine
    Yang, Yuanchu J.
    Ye, Cheng
    Schultz, Nikolaus
    Riely, Gregory J.
    McCarthy, Caroline G.
    Rizvi, Hira
    Schrag, Deborah
    Kehl, Kenneth L.
    Lepisto, Eva M.
    Yu, Celeste
    Bedard, Philippe L.
    Fabbri, Daniel
    Warner, Jeremy Lyle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Divarasib Versus Adagrasib or Sotorasib in Pretreated KRAS G12C+Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Gadgeel, S.
    Rahman, A.
    Osaghae, U.
    Fernando, T. M.
    Lin, M. T.
    Koli, K.
    Meyenberg, C.
    Mathisen, M.
    Skoulidis, F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S349 - S349
  • [34] Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation
    Zheng, Xinting
    Luo, Jiamin
    Liu, Wei
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    Lin, Lizhu
    DRUGS OF TODAY, 2022, 58 (04) : 175 - 185
  • [35] KRAS G12C mutations in non-small cell lung cancer
    Li, J. J.
    Wu, X. J.
    Farzin, M.
    Bray, V.
    Williamson, J.
    Pal, A.
    Yip, P. Y.
    Hagelamin, A.
    Ding, P.
    Nindra, U.
    Vinod, S.
    French, B.
    Chua, W.
    Gupta, R.
    Cooper, W. A.
    Wang, B.
    Lee, C. S.
    HISTOPATHOLOGY, 2024, 85 : 25 - 25
  • [36] Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
    Yamada, T.
    Morimoto, K.
    Hirai, S.
    Katayama, Y.
    Kunimasa, K.
    Sasaki, T.
    Nishida, M.
    Watanabe, S.
    Shiotsu, S.
    Uehara, H.
    Takayama, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [37] Safety and efficacy of HS-10370 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Dong, Xiaorong
    Meng, Xiangjiao
    Zhang, Yan
    Wang, Yan
    Chen, Jianhua
    Han, Liang
    Wang, Qiming
    Lin, Zhong
    Wei, Hongying
    Lin, Siheng
    Li, Chuan
    Wu, Qiong
    CANCER RESEARCH, 2024, 84 (07)
  • [38] COST PER RESPONDER ANALYSIS COMPARING ADAGRASIB AND SOTORASIB IN PATIENTS WITH KRAS G12C-MUTATED PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Berardi, A.
    Laurie, M.
    Theriou, C.
    Orsini, I
    Bouwmeester, W.
    Gao, S.
    Korytowsky, B.
    VALUE IN HEALTH, 2023, 26 (12) : S119 - S120
  • [39] Treatment patterns and overall survival in patients with BRAF-mutated metastatic non-small cell lung cancer
    Goyal, R. K.
    Kron, A.
    Wolf, J.
    Mazieres, J.
    Chouaid, C.
    Davis, K. L.
    Perrinjaquet, M.
    Knoll, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Clinical Characteristics and Outcomes of Patients with BRAF Mutated Non-Small Cell Lung Cancer
    Mu, Y.
    Xing, P.
    Li, Y.
    Hao, X.
    Ying, J.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S868 - S868
12345